1[1]Oka M,Iizuka N,Yamamoto K,Gondo T,Abe T,Hazama S,Akitomi Y,Koishihara Y,Ohsugi Y,Ooba Y,Ishihara T,Suzuki T.The influence of interleukin -6 on the growth of human esophageal cancer cell lines.J Interferon Cytokine Res 1996; 16:1001-1006
2[2]Miki S,Iwano M,Miki Y,Yamamoto M,Tang B,Yokokawa K,Sonoda T,Hirano T,Kishimoto T.Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas.FEBS Lett 1989; 250:607-610
3[3]Lee JD,Sievers TM,Skotzko M,Chandler CF,Morton DL,McBride WH,Economou JS.Interleukin-6 production by human melanoma cell lines.Lymphokine Cytokine Res 1992; 11:161-166
4[4]Siegall CB,Schwab G,Nordan RP,FitzGerald DJ,Pastan Ⅰ.Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells.Cancer Res 1990; 50:7786-7788
5[5]Watson JM,Sensintaffar JL,Berek JS,Martinez-Maza O.Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures.Cancer Res 1990;50:6959-6965
6[6]Bataille R,Jourdan M,Zhang XG,Klein B.Serum levels of interleukin 6,a potent myeloma cell growth factor,as a reflect of disease severity in plasma cell dyscrasias.J Clin Invest 1989;84:2008-2011
8[8]Seguchi T,Yokokawa K,Sugao H,Nakano E,Sonoda T,Okuyama A.Interleukin-6 activity in urine and serum in patients with bladder carcinoma.J Urol1992; 148:791-794
9[9]Yanagawa H,Sone S,Takahashi Y,Haku T,Yano S,Shinohara T,Ogura T.Serum levels of interleukin-6 in patients with lung cancer.Br J Cancer 1995; 71:1095-1098
10[10]Berek JS,Chung C,Kaldi K,Watson JM,Knox RM,MartinezMaza O.Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer.Am J Obstet Gynecol 1991; 164:1038-1042; discussion 1042-1043
8Alberg AJ, Selhuh J, Shah gV, et al. The risk of cervical cancer in relation to serum concentration of folate, vitamineBlz and homocysteine [ J]. Cancer Epidemiology Biomarkers and Prevention, 2000,9 (7) :761 - 764.
9Kitadai Y, I-Iaruma K, Mukaida N, et al. Regulation of disease pro- gression genes in human gastric carcinoma cells by interleukin-8 [ J ]. Clin Cancer Res,2000,6 (7) :2735-2740.
10Heidemann J, Ogawa H,DwineU MB, et al. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2 [ J ]. J Biol Chem, 2003,278 ( 10 ) : 8508- 8515.
